May 27, 2015
NIAID announces findings from the START study
Today, May 27th, the results from the START study were announced. START - a major international randomized clinical trial - has found that HIV-positive individuals have a considerably lower risk of developing AIDS or other serious illnesses if they start taking antiretroviral drugs sooner, when their CD4+ T-cell count—a key measure of immune system health—is higher, instead of waiting until the CD4+ cell count drops to lower levels. Together with data from previous studies showing that antiretroviral treatment reduced the risk of HIV transmission to uninfected sexual partners, these findings support offering treatment to everyone with HIV.
See press release and question and answers from NIAID: